Literature DB >> 2605235

Fourier-transform infrared studies on cation binding to native and modified purple membranes.

M Duñach1, E Padrós, A Muga, J L Arrondo.   

Abstract

Fourier-transform infrared spectroscopy has been used to examine the structural differences in the protein moiety between the native purple and the deionized blue membranes, both at pH 5.0. The spectra demonstrate that deionization of purple membrane decreases the content of the distorted alpha II-helices in favor of the more common alpha I-helices. Changes in the signals from beta-turns are also observed. The changes corresponding to the carboxyl groups suggest that deionization leads to a decrease in the strength of the hydrogen bonds involving carboxyl groups. Most of these effects are reversed progressively upon binding of one to five Mn2+ per bacteriorhodopsin to the deionized membrane. Binding of Hg2+ to the deionized membranes does not restore the purple color but induces global changes similar to, but less intense than, those brought about by Mn2+ binding. However, the effects attributed to the carboxyl groups are opposite to those found for Mn2+. Schiff base reduction or bleaching induces a decrease of the content of the alpha II-helix in favor of the alpha I-helix and a decrease in the strength of hydrogen bonds to carboxyl groups. Deionization of these modified membranes leads to a further loss in the alpha II content. These results indicate a conformational rearrangement of the protein structure between the native purple membrane and the deionized membrane, which could arise from surface potential changes elicited by bound cations. The changes observed in the carboxyl groups suggest that some of them are located structurally close to the retinal environment and may be involved in cation binding.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605235     DOI: 10.1021/bi00448a038

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Fourier transform infrared study of the effect of different cations on bacteriorhodopsin protein thermal stability.

Authors:  Colin D Heyes; Jianping Wang; Laurie S Sanii; Mostafa A El-Sayed
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

2.  Calorimetric and spectroscopic studies of the thermotropic phase behavior of lipid bilayer model membranes composed of a homologous series of linear saturated phosphatidylserines.

Authors:  R N Lewis; R N McElhaney
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Dramatic in situ conformational dynamics of the transmembrane protein bacteriorhodopsin.

Authors:  J E Draheim; N J Gibson; J Y Cassim
Journal:  Biophys J       Date:  1991-07       Impact factor: 4.033

4.  Combination of extended X-ray absorption fine structure spectroscopy with lipidic cubic phases for the study of cation binding in bacteriorhodopsin.

Authors:  Alex Perálvarez-Marín; Francesc Sepulcre; Mercedes Márquez; Maria Grazia Proietti; Esteve Padrós
Journal:  Eur Biophys J       Date:  2011-06-12       Impact factor: 1.733

5.  Analysis of conformational changes in bacteriorhodopsin upon retinal removal.

Authors:  J Cladera; J Torres; E Padrós
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

6.  Location of a cation-binding site in the loop between helices F and G of bacteriorhodopsin as studied by 13C NMR.

Authors:  S Tuzi; S Yamaguchi; M Tanio; H Konishi; S Inoue; A Naito; R Needleman; J K Lanyi; H Saitô
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

7.  Proton transfer reactions in native and deionized bacteriorhodopsin upon delipidation and monomerization.

Authors:  Colin D Heyes; Mostafa A El-Sayed
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

8.  Experimental and theoretical characterization of the high-affinity cation-binding site of the purple membrane.

Authors:  L Pardo; F Sepulcre; J Cladera; M Duñach; A Labarta; J Tejada; E Padrós
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.